Randomized Study of Hormonal Regulation of Infantile Hemangioma

Summary

OBJECTIVES: I. Evaluate the clinical efficacy of leuprolide, a gonadotropin-releasing hormone agonist (GnRHa), in treating infants with vision-endangering or large, disfiguring hemangiomas. II. Assess the impact of GnRHa on growth and development during infancy. III. Assess the safety of GnHRa in these patients.

Timeline

Start

1993-07

Primary completion

—

Completion

2000-06

Drugs

Indications